Skip to main content
. 2020 Dec 2;11:550201. doi: 10.3389/fpsyt.2020.550201

Table 9.

Distribution of other concomitant drugs reported with aripiprazole and risperidone grouped according to the Anatomical Therapeutic Chemical (ATC) classification system I level.

ATC* Aripiprazole N (%) Risperidone N (%) p
A 51 (7.7) 34 (4.7) <0.05
B 7 (1.1) 5 (0.7) <0.05
C 65 (9.8) 37 (5.1) <0.05
D 10 (1.5) 1 (0.1) <0.05
G 4 (0.6) 3 (0.4) >0.05
H 11 (1.7) 18 (2.5) >0.05
J 11 (1.7) 25 (3.5) <0.05
L 3 (0.5) 6 (0,8) >0.05
M 9 (1.4) 8 (1.1) >0.05
N 454 (68.4) 542 (75.0) <0.05
P 0 (0.0) 2 (0.3)
R 35 (5,3) 29 (4.0) >0.05
S 1 (0.2) 1 (0.1) >0.05
V 3 (0.5) 3 (0.4) >0.05
UN** 0 (0.0) 9 (1.2)
TOT 664 (100) 723 (100)
*

ATC, Anatomical Therapeutic Chemical;

**

UN, Unknown.

Anatomical Therapeutic Chemical classification system I level Legend.

ATC-A, Alimentary Tract and metabolism; ATC-B, Blood and blood-forming organs; ATC-C, cardiovascular system; ATC-D, Dermatologicals; ATC-G, Genito-urinary system and sex hormones; ATC-H, Systemic hormonal preparation, excluding sex hormones, and insulins; ATC-J, antiinfectives for systemic use; ATC-L, Antineoplastic and immunomodulating agents; ATC-M, Muscolo-skeletal system; ATC-N, Nervous system; ATC-P, Antiparasitic products, insecticides, and repellents; ATC-R, Respiratory system; ATC-S, Sensory organs; ATC-V, Various.